NCT05809947

Brief Summary

The study is a 5-week human study including 24 18-35 year old healthy men. Each participant will have muscle injury and tendon strain induced in one leg using neuromuscular electrical stimulation in conjunction with forced lengthening contractions. The investigators will monitor the recovery from injury/strain over a 4 week period, in which half of the subjects will receive growth hormone (somatropin) to stimulate the connective tissue synthesis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 17, 2023

Completed
25 days until next milestone

Study Start

First participant enrolled

April 11, 2023

Completed
1 day until next milestone

First Posted

Study publicly available on registry

April 12, 2023

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 3, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 3, 2024

Completed
Last Updated

January 9, 2024

Status Verified

January 1, 2024

Enrollment Period

9 months

First QC Date

March 17, 2023

Last Update Submit

January 8, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Effect of somatropin on muscle protein synthesis 14 days after injury

    The difference in fractional synthesis rate in muscle proteins 14 days after injury with or without 14 days treatment with somatropin. Measured using deuterated water

    14 days

Secondary Outcomes (14)

  • Muscle protein synthesis 7 days after injury

    7 days

  • Muscle protein synthesis 14 days after injury

    14 days

  • Muscle protein breakdown 14 days after injury

    14 days

  • Muscle protein breakdown 7 days after injury

    7 days

  • Muscle protein breakdown 28 days after injury

    28 days

  • +9 more secondary outcomes

Study Arms (2)

Growth hormone/somatropin

EXPERIMENTAL

Somatropin over two weeks (33.3 ug/kg/day in the first week, 50 ug/kg/day in the second week)

Other: Neuromuscular electrical stimulation

Placebo

PLACEBO COMPARATOR

Injections of placebo/saline over two weeks

Other: Neuromuscular electrical stimulation

Interventions

One bout of neuromuscular electrical stimulation in conjunction with forced lengthening contractions on one leg

Also known as: Neuromuscular electrical stimulation using Theta 4 channel stimulator from Chattanooga. Coupled with forced eccentric contractions.
Growth hormone/somatropinPlacebo

Eligibility Criteria

Age18 Years - 35 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy men
  • BMI between 18.5-30 kg/m\^2

You may not qualify if:

  • Smoking
  • Regular strength training within the last 3 months
  • Current or former use of anabolic steroids or growth hormone
  • Use of corticosteroids in the last 3 months
  • Use of blood thinning medication
  • Use of medication which can affect muscle protein synthesis
  • Current or former drug og alcohol abuse
  • Knee pain
  • Previous participation in studies using deuterated water or alanine tracers

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institute of Sports Medicine Copenhagen

Copenhagen, 2400, Denmark

Location

MeSH Terms

Conditions

Wounds and Injuries

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator, postdoc

Study Record Dates

First Submitted

March 17, 2023

First Posted

April 12, 2023

Study Start

April 11, 2023

Primary Completion

January 3, 2024

Study Completion

January 3, 2024

Last Updated

January 9, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will not share

The IPD will be made available upon individual request once the study is finalised and published.

Locations